News
AVTX
21.75
+357.89%
17.00
Health Care Sector Update for 03/28/2024: KOD, AVTX, WBA, LLY, AMZN
NASDAQ · 3h ago
Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
U.S. Stocks traded mixed toward the end of trading on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. Energy shares jumped by 1.1% on Thursday while communication services shares fell by 0.2%. European shares closed mostly higher on Thursday with Asian markets mostly higher.
Benzinga · 4h ago
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. The company reported a wider-than-expected fourth-quarter loss. Avalo Therapeutics, Inc. Shares jumped 430% in today's mid-day session. Other stocks moving in the market include RH, Ggoorks and Xilio.
Benzinga · 5h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Avalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday's regular session. The company's market cap stands at $17.6 million. Biodexa Pharmaceuticals and Ontrak stock increased by 71.82% and 37.66% respectively. Q4 earnings came out today.
Benzinga · 7h ago
Gold Gains 1%; Walgreens Narrows Earnings Forecast
U.S. Stocks traded slightly higher midway through trading on Thursday. The Dow traded up 0.06% and the S&P 500 gained around 0.1%. Walgreens Boots Alliance reported better than expected second-quarter earnings and tightened FY24 guidance. Energy shares jumped by 0.6% while communication services shares fell 0.2%. Asian markets closed mostly higher in Asia.
Benzinga · 7h ago
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
REX American Resources Corporation shares jumped 23.2% to $54.15 after upbeat quarterly earnings. Avalo Therapeutics, Inc. Shares gained 430% in Thursday's session. The S&P 500 gained around 0.1% on Thursday. RH posted weaker-than-expected results for its fourth quarter.
Benzinga · 8h ago
US Stocks Flat; Initial Jobless Claims Fall To 210,000
U.S. Stocks traded mixed on Thursday. The Dow Jones index traded down 0.02% while the NASDAQ fell 0.08%. European shares were higher on Thursday; Asian markets closed mostly higher. Initial jobless claims fell by 2,000 to 210,000 in the week ending March 23. In commodity news, oil traded up 1.2% to $82.34 and gold traded up 0.6%.
Benzinga · 9h ago
Micro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin Disorder
Avalo Therapeutics announced the acquisition of a Phase 2-ready anti-IL-1β mAb. The company plans to pursue the development of AVTX-009 in the treatment of hidradenitis suppurativa. The drug was originally developed by Eli Lilly.
Benzinga · 9h ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, B Riley, Xilio Therapeutics
Wall Street's main stock indexes set to open flat on Thursday in thin trading ahead of Easter break. Dow e-minis up 0.11%, S&P 500 and Nasdaq 100 down 0.02%. Top three NYSE percentage gainers premarket: Cazoo Group, Xilio Therapeutics. Gold miners rise on U.S. Interest rate cut bets. B Riley Financial up 6.7% in premarket.
Reuters · 10h ago
Why Is Urban-gro (UGRO) Stock Down 18% Today?
Urban-gro (NASDAQ:UGRO) stock is taking a beating on Thursday following the release of its Q4 2023 earnings report. The indoor controlled environment agriculture company reported a loss of 34 cents per share and revenue of $15 million. With this negative earnings report, UGRO stock is down 17.9% on Thursday morning. We have all of the hottest stock market news worth reading on Thursday. Also, check out the biggest pre-market stock movers this morning.
Investorplace · 11h ago
Market-Moving News for March 28th
Xilio Therapeutics shares are trading higher after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. Avalo announced a $11.3 million private placement equity financing for its anti-IL-1β program.
Benzinga · 11h ago
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast. The company's shares jumped 9.4% to $324.99 in pre-market trading. Avalo Therapeutics, Inc. Gained 256.6% on Wednesday.
Benzinga · 11h ago
Why Is Binah Capital (BCG) Stock Up 93% Today?
Binah Capital (NASDAQ:BCG) stock is taking off on Thursday following the debut of the wealth management company’s shares on the Nasdaq Exchange yesterday. Binah Capital shares went public on Wednesday following a special purpose acquisition company merger with Kingswood. More than 177,000 shares of BCG stock have changed hands during pre-market hours. The company”s shares are up 93.2% as of Thursday morning. InvestorPlace has all of the hottest stock market news for Thursday.
Investorplace · 11h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. Xilio Therapeutic (XLO) stock moved upwards by 223.94% during the session. Akanda (AKAN) shares increased by 27.1% and INVO Bioscience (INVO) stock increased by 16.36%. NuCana (NCNA) stock declined by 19.8% in the pre- market.
Benzinga · 11h ago
Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?
Avalo Therapeutics is up 325.7% after completing its acquisition of AlmataBio. The company secured $185 million through a private placement. AVTX stock is also up today after the company acquired AVTX-009. This is the biggest pre-market stock market news on Thursday.
Investorplace · 11h ago
BUZZ-U.S. STOCKS ON THE MOVE-Crypto stocks, Akebia Therapeutics, Sprinklr
U.S. Stock index futures were lackluster on Thursday. Investors await more data to gauge the state of the economy and the Fed's policy path. The top three NYSE percentage gainers premarket were Akebia Therapeutics, Sprinklr. Crypto stocks up as bitcoin, ether prices recover from two-day slide.
Reuters · 11h ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Moving stocks this morning are public debuts, earnings reports and more. Avalo Therapeutics stock is rocketing more than 268% after going public yesterday. Urban-gro stock is diving more than 18% with the release of its latest earnings report. 10 of the biggest pre-market stock movers are in the biotech sector.
Investorplace · 12h ago
Avalo Therapeutics’ Strategic Expansion and Leadership Revamp
TipRanks · 13h ago
BUZZ-Avalo Therapeutics surges on buyout of privately held AlmataBio
Avalo Therapeutics surges on buyout of privately held AlmataBio. Shares of biotech co surge over four-fold to $20.9 in extended trading. Co says it has acquired Almata bio to gain access to its experimental drug being developed for an inflammatory skin condition.
Reuters · 1d ago
More
Webull provides a variety of real-time AVTX stock news. You can receive the latest news about Avalo Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About AVTX
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. It is focused on advancing a pipeline that emphasizes high value potential first-in-class biologics focused on dysregulated inflammation through the LIGHT-signaling network. Its pipeline includes AVTX-002, and AVTX-008. AVTX-002 is an Anti-LIGHT monoclonal antibody for treatment of non-eosinophilic asthma, Crohn’s Disease, and COVID-19 acute respiratory distress syndromes. AVTX-008 is a fully human B and T lymphocyte attenuator (BTLA) agonist fusion protein that is being evaluated for several immune dysregulation disorders.